Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Can response to TACE predict survival after liver transplantation in patients with hepatocellular carcinoma?

Nature Clinical Practice Gastroenterology & Hepatology volume 4, pages 540–541 (2007)Cite this article

boxed-textMillonig G et al. (2007) Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 13: 272–279

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Lopez PM et al. (2006) Systematic review: evidence-based management of hepatocellular carcinoma—an updated analysis of randomized controlled trials. Aliment Pharmacol Ther 23: 1535–1547

    CAS  Article  Google Scholar 

  2. Yao FY et al. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394–1403

    CAS  Article  Google Scholar 

  3. Roayaie S et al. (2002) Long term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinoma greater than 5 cm. Ann Surg 235: 533–539

    Article  Google Scholar 

  4. Yao FY et al. (2005) A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 11: 1505–1514

    Article  Google Scholar 

  5. Lesurtel M et al. (2006) Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant 6: 2644–2650

    CAS  Article  Google Scholar 

  6. Otto G et al. (2006) Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transplant 12: 1260–1267

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Jones, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029, USA paul.martin@mountsinai.org

Affiliations

  1. P Martin is a Professor of Medicine at Mount Sinai School of Medicine, New York, NY, USA.

    Paul Martin

Authors
  1. Paul Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Martin, P. Can response to TACE predict survival after liver transplantation in patients with hepatocellular carcinoma?. Nat Rev Gastroenterol Hepatol 4, 540–541 (2007). https://doi.org/10.1038/ncpgasthep0925

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpgasthep0925

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing